Immediate Impact
2 from Science/Nature 57 standout
Citing Papers
Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States
2023 Standout
Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants
2023 Standout
Works of Josef Weigl being referenced
Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial
2015
Seasonality of Respiratory Syncytial Virus-Positive Hospitalizations in Children in Kiel, Germany, over a 7-Year Period
2002
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Josef Weigl | 1137 | 513 | 268 | 45 | 1.5k | |
| Tim Wreghitt | 1348 | 412 | 148 | 59 | 2.0k | |
| Aaron Webster | 977 | 544 | 121 | 58 | 2.2k | |
| T. R. Cate | 1479 | 557 | 213 | 47 | 2.0k | |
| Pieter L. A. Fraaij | 1158 | 894 | 353 | 70 | 2.2k | |
| Therese Popow‐Kraupp | 1309 | 518 | 342 | 47 | 1.5k | |
| K. G. Nicholson | 1243 | 242 | 573 | 30 | 1.9k | |
| Geneviève Billaud | 744 | 743 | 144 | 41 | 1.4k | |
| J. Petitjean | 1151 | 1018 | 266 | 69 | 1.8k | |
| Rami Sommerstein | 608 | 701 | 245 | 58 | 1.6k | |
| Joseph A. Bell | 808 | 652 | 126 | 56 | 1.5k |
All Works
Loading papers...